Lilly lives with a rare disease and much zest for life - A Rare Life: One Woman's Battle with an Ultra-Rare Immune Disorder

Rare Disease Day, held annually on the last day of February, brings attention to the challenges faced by individuals living with uncommon conditions, fostering solidarity among patients. For 20-year-old Lilly Hiebenthal from Germany, this day holds deep personal significance, as she battles an immune disorder so rare that only about 20 cases exist worldwide.

Lilly was diagnosed in 2006 with Evans syndrome, a severe immune system defect. At the time, doctors had recorded only 11 other cases globally. Her condition leaves her constantly fighting cold-like symptoms, painful skin eczema, and intestinal inflammation, while fatigue weighs heavily on her daily life.

Despite these challenges, Lilly has cultivated a mindset of gratitude, focusing on what she can still achieve rather than what her illness restricts. Her resilience comes as no surprise, given the harsh reality of rare diseases: in Germany alone, around four million people live with such conditions, many of which remain incurable and life-shortening.

Advances in genetic diagnostics have improved diagnosis rates in recent years. Specialised centres now operate in many German university hospitals, helping patients navigate the often years-long journey to a confirmed diagnosis. For Lilly, a potential cure exists in the form of a stem cell transplant. However, the procedure is high-risk, demands a compatible donor, and remains far from guaranteed.

Worldwide, roughly 8,000 diseases are classified as rare. Many patients endure a gruelling path to diagnosis, with delays stretching up to five years. Lilly's story reflects both the progress made and the hurdles still faced by those living with these often invisible illnesses.

Lilly's experience underscores the importance of Rare Disease Day in raising awareness and connecting patients. While medical advancements offer hope, the road to diagnosis and treatment remains long for many. For now, she continues to live with her condition, supported by a growing network of research and advocacy.